Synonyms:Ketanserin, 74050-98-9, Ketanserin tartrate, Ketanserinum, Ketaserin, Ketanserina, Ketanserine, 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione, R-41468, R-41,468, C22H22FN3O3, R 41468, [3H]-Ketanserin, 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione, CHEMBL51, 3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione, 97F9DE4CT4, CHEBI:6123, DTXSID3023188, 3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione, Perketan, Serepress, [3H]ketanserin, 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-, NSC-758959, NCGC00021146-06, 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-ethyl)quinazoline-2,4(1H,3H)-dione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione, 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione, 2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-, Ketanserine [INN-French], Ketanserinum [INN-Latin], Ketanserina [INN-Spanish], DTXCID103188, Perketal, Serefrex, Taseron, 83846-83-7, Vulketan Gel, 3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4(1H,3H)-quinazolinedione, CAS-74050-98-9, R 41,468, Ketanserin (USAN/INN), EINECS 277-680-2, UNII-97F9DE4CT4, Kentanserin, Ketanserin [USAN:INN:BAN], R-41-468, 3-[2-[4-(p-Fluorobenzoyl)piperidino]ethyl]-2,4-(1H,3H)-quinazolinedione, 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione, Tocris-0908, KETANSERIN [MI], KETANSERIN [INN], Spectrum2_001713, KETANSERIN [USAN], Ketanserin (Vulketan Gel), Biomol-NT_000096, GTPL88, KETANSERIN [MART.], KETANSERIN [WHO-DD], R41,468, SCHEMBL34294, GTPL197, MLS006010073, SPECTRUM1505346, SPBio_001726, BPBio1_001356, BDBM21395, HMS1923O11, HMS2090H18, HMS2094I03, HMS3655H14, HMS3887G17, Pharmakon1600-01505346, Tox21_110865, CCG-39512, MFCD00083392, NSC758959, PDSP1_000639, PDSP2_000634, s2232, AKOS015895130, Tox21_110865_1, AC-2024, CS-6055, DB12465, GS-3601, SDCCGSBI-0051158.P004, (+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione, 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione, NCGC00021146-01, NCGC00021146-02, NCGC00021146-03, NCGC00021146-04, NCGC00021146-05, NCGC00021146-07, NCGC00021146-08, NCGC00021146-09, NCGC00021146-12, NCGC00021146-22, NCGC00024865-01, NCGC00024865-02, NCGC00024865-03, NCGC00024865-04, NCGC00024865-05, HY-10562, SMR001550601, SBI-0051158.P003, DB-055834, FT-0630827, FT-0653664, K0051, SW196882-3, C07464, D02363, A838000, L000764, Q415997, R41 468, W-104435, BRD-K49671696-001-02-1, BRD-K49671696-347-02-8, F2173-1039, Z2216887910, KETANSERIN, Ketanserin tartrate hydrate, KETANSERIN TARTRATE, 2,4(1H,3H)-Quinazolinedione,3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-, 2,4(1h,3h)quinazolinedione,3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-, 3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione #, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]-ethyl]-2,4-[1H, 3H]-quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4-(1H,3H)-quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione;Ketanserin, 3-{2-[4-(4-fluoro-benzoyl)-piperidin-1-yl]-ethyl}-1h-quinazoline-2,4-dione, 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione
Pubchem:PUBCHEM:3822
Id:efddf75d-a029-5afd-af8c-7524e4bdd43a
Description:nan
